Malignant Female Reproductive System Neoplasm Clinical Trial
Official title:
Counseling Intervention During Radiation Therapy for Women With Gynecologic Cancer
This phase I trial studies a sexual health counseling intervention during radiation therapy in improving quality of life for women with gynecologic cancer. Women with gynecologic cancer often suffer long-term complications from treatment that can affect their physical and psychological well-being. An early sexual health counseling intervention prior to and after radiation may improve symptoms management and reduce the physical and psychological effects of treatment.
PRIMARY OBJECTIVE: I. To determine the feasibility of a sexual health counseling intervention before and after pelvic radiation for women with gynecologic cancers. SECONDARY OBJECTIVE: I. To preliminarily evaluate the efficacy of a sexual health counseling intervention on patient reported outcomes in quality of life, sexual function, and genitourinary symptoms. OUTLINE: Patients receive sexual health counseling prior to starting and at the completion of radiation. After completion of study, patients are followed up at 1 and 6 months after radiation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03968406 -
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
|
Phase 1 | |
| Completed |
NCT01641068 -
Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms
|
N/A | |
| Active, not recruiting |
NCT04266886 -
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
|
N/A | |
| Active, not recruiting |
NCT01715168 -
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
|
Phase 1 | |
| Suspended |
NCT01356329 -
Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
|
Phase 3 | |
| Recruiting |
NCT06089083 -
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
|
||
| Completed |
NCT02518308 -
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
|
N/A | |
| Active, not recruiting |
NCT03776253 -
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer
|
N/A | |
| Active, not recruiting |
NCT05556772 -
Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic
|
N/A | |
| Recruiting |
NCT06126276 -
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
|
Phase 2 | |
| Terminated |
NCT03345784 -
Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers
|
Phase 1 | |
| Completed |
NCT01387841 -
Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting
|
Phase 2 | |
| Completed |
NCT01433302 -
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
|
N/A | |
| Completed |
NCT02423876 -
Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery
|
Phase 3 | |
| Active, not recruiting |
NCT01552434 -
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
|
Phase 1 | |
| Completed |
NCT04456140 -
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
|
Phase 1 | |
| Terminated |
NCT02818530 -
Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ultrasound
|
N/A | |
| Recruiting |
NCT05786456 -
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
|
N/A | |
| Recruiting |
NCT05625360 -
REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss
|
Phase 3 | |
| Completed |
NCT04258631 -
Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies
|
Phase 4 |